Analysis of NF2 Gene Mutation in Acoustic Neuroma

ZHANG Zhi-hua,SUN lian-hua,CHEN Hong-sai,WANG Zhao-yan,YANG Tao,WU Hao

DOI: https://doi.org/10.3969/j.issn.1672-2922.2013.01.004

2013-01-01

Abstract:Objective To study NF2 gene mutations in acoustic neuroma. Methods Tumor tissue and blood samples from 84 patients with acoustic neuroma undergone surgery from January 2007 to December 2010 were collected in this study. Standard sequencing was used to detect NF2 gene mutation. Furthermore, multiple ligation-dependant probe amplification (MLPA) was performed on 30 patients to detect large deletions in the NF2 gene. Results NF2 gene mutation rate on standard sequencing was 39.3% among tumor specimens, but zero in blood samples. The rate of frame shift, splice site, nonsense and missence mutation was 48.5%, 21.2%, 24.2% and 6.1%, respectively. NF2 gene mutations occurred between exon 1 and 15. The exon 8 was the most favorite exon of mutations (15.2%). The rate of mutation in amino terminus, joinning region, α-helical structure and carboxyl terminus were 63.6%, 6.1%, 21.2% and 6.1%, respectively. Large deletions were detected in 73.3% of the patients via MLPA, of which 56.7% were located in amino terminus. The rate of NF2 gene mutation or large deletion detection increased to 80.0% when MLPA and standard sequencing were combined. Conclusions Somatic NF2 mutations and large deletions in the NF2 gene are frequent in sporadic acoustic neuroma. Combined MLPA and standard sequencing improves efficacy of NF2 gene mutation screening.